[What is assured in the treatment of heart arrhythmia?].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000404:Ajmaline / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001285:Atropine / Q000627:therapeutic use; D001919:Bradycardia / Q000188:drug therapy*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy*; D006327:Heart Block / Q000188:drug therapy*; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy*; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000404:Ajmaline; D009921:Metaproterenol; D010672:Phenytoin; D001285:Atropine; D008012:Lidocaine; D014700:Verapamil; D011802:Quinidine; D011342:Procainamide
Was ist gesichert in der Therapie von Rhythmusstörungen des Herzens.